✦ LIBER ✦

Safety and Efficacy of Foscarnet for Preemptive Therapy Against Cytomegalovirus Reactivation After Unrelated Cord Blood Transplantation

✍ Scribed by A. Takami; K. Mochizuki; S. Ito; C. Sugimori; T. Yamashita; H. Asakura; H. Okumura; S. Nakao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced dose of foscarnet as preemptive

✍ H. Narimatsu; M. Kami; D. Kato; T. Matsumura; N. Murashige; E. Kusumi; K. Yuji; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Preemptive therapy with ganciclovir 5 mg

✍ Tomonari, A; Takahashi, S; Ooi, J; Tsukada, N; Konuma, T; Kobayashi, T; Takasugi 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Ganciclovir-related neutropenia after pr

✍ Akira Tomonari; Tohru Iseki; Satoshi Takahashi; Jun Ooi; Toshiki Yamada; Kashiya 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 78 KB

Monitoring and Preemptive Rituximab Ther

✍ Anne H. Blaes; Qing Cao; John E. Wagner; Jo-Anne H. Young; Daniel J. Weisdorf; C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Efficacy and Safety of Valgancyclovir as

✍ C. Dı́az-Pedroche; C. Lumbreras; P. Del Valle; R. San Juan; S. Hernando; D. Folg 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

208: The Use, Safety, and Efficacy of Da

✍ A. Mohamed; D. Niedzwiecki; J.H. Baker; R. Vinesett; P.L. Martin; T.A. Driscoll; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB